Skip to content

Improving Locomotor Learning With Brain Stimulation

Enhancing Locomotor Learning With Motor Imagery and Transcranial Direct Current Stimulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06414213
Acronym
ELLMITS
Enrollment
38
Registered
2024-05-16
Start date
2022-09-20
Completion date
2022-12-22
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor Learning

Keywords

randomized, double-blinded, tDCS, motor imagery, functional near-infrared spectroscopy (fNIRS), controlled trial

Brief summary

The primary goal of this research was to assess the practicality and initial effectiveness of a motor imagery (MI) intervention combined with elements of action observation (AO), alongside active or sham transcranial direct current stimulation (tDCS) over the prefrontal cortex (PFC), on locomotor learning in healthy adults. Feasibility was determined by examining recruitment rates, participant engagement, and safety measures. The efficacy of the intervention was gauged by analyzing the time taken to complete tasks and changes in cerebral blood flow immediately after the intervention and one week later. The study was guided by three main hypotheses: (1) the intervention techniques would be well-received and safe for the participants; (2) compared to a control group, MI training would lead to better learning outcomes and retention of learning; (3) in comparison to the control and sham tDCS groups, active tDCS would result in superior learning outcomes and retention of learning.

Detailed description

The study implemented a double-blind, randomized, controlled trial design. Participants were tested three times over 7 days. After study enrollment, the participants were randomly assigned to one of three groups: MIActive (receiving active tDCS stimulation and participating in MI protocol), MISham (receiving sham tDCS stimulation and participating in MI protocol), and Control (receiving no stimulation and participating in an unrelated video-watching task) by a research member not associated with data collection. Allocation ratio was 1:1:1 and a block randomization approach was employed to maintain an equal distribution of participants across the three groups throughout the study. Study participants and assessors were blinded to assignment of active or sham tDCS. The independent variables were time (pre, post, and retention trials) and group (MIActive, MISham and Control), and the dependent variables were time to completion of a complex obstacle course and the amount of change in oxygenated hemoglobin (ΔO2Hb) during performance of that task.

Interventions

Participants watched a standardized video sequence that consisted of an individual completing twenty walking trials (twenty video clips-each clip represents one trial). Participants were instructed to place their focus intently on the person performing the obstacle course and try to imagine themselves doing the skill. Periodically, a reminder would appear to help focus and redirect participant's attention to different aspects of the video or different versions of imagery (visual or kinesthetic). Participants will watch the video first at normal play speed and then in slow motion after a short break (30 secs to 1 min). Total training time will be approximately 20 mins which is consistent with the duration of the locomotor intervention and duration of stimulation.

DEVICEActive tDCS

The participants received a 20-minute active session of tDCS at a 2-milliamp current.

DEVICESham tDCS

The participants received a 20-minute session of sham tDCS.

Sponsors

Appalachian State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female adults age 18 and older * Freely ambulatory (no assistive walking aids)

Exclusion criteria

* Failure to meet specific inclusion criteria * History or presence of any neurological disease * Low visual ability, operationally defined as visual acuity less than 20/70 on the standard eye chart * Extreme difficulty performing walking tasks due to low visual ability * Clinical judgment of the investigative team * Additionally, subjects who are determined to be at increased risk for adverse events during the tDCS procedure, as determined by the tDCS screening questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Prefrontal Cortical ActivityBaseline to 1 week follow upFunctional near infrared spectroscopy (fNIRS) monitor (OctaMon by Artinis Medical Systems), changes in oxygenated hemoglobin concentration (O2Hb) relative to a baseline task
Adherence to InterventionsBaseline to 1 week follow upnumber of sessions attended
Retention of ParticipantsBaseline to 1 week follow upnumber of participants completing intervention and follow-up assessment
Adverse Events in Each Study ArmBaseline to 1 week follow upNumber of unexpected and/or serious adverse events
Time to CompletionBaseline to 1 week follow upRecorded time to complete the obstacle course

Secondary

MeasureTime frameDescription
Kinesthetic and Visual Imagery Questionnaire (KVIQ)Baseline to 1 week follow upThe Kinesthetic and Visual Imagery Questionnaire (KVIQ-10) measures the ability to imagine movements. This test evaluates the subject's ability to see (visual imagery) and feel (kinesthetic imagery) movements. The KVIQ-10 total score ranges from 10 to 50 (visual and kinesthetic subscale scores each range from 5 to 25).The KVIQ consists of 10 items, (5 movements for each scale), each item being a separate movement followed by rating the ease or difficulty of generating those self-images on a 5-point Likert scale (where 1 = no image or sensation and 5 = Image as clear as seeing or as intense as executing the action). Higher scores reflect higher imagery abilities.

Countries

United States

Participant flow

Participants by arm

ArmCount
MI/Active tDCS
The participants received active tDCS current and participated in the Motor Imagery intervention. Motor Imagery (MI): Participants watched a standardized video sequence that consisted of an individual completing twenty walking trials (twenty video clips-each clip represents one trial). Participants were instructed to place their focus intently on the person performing the obstacle course and try to imagine themselves doing the skill. Periodically, a reminder would appear to help focus and redirect participant's attention to different aspects of the video or different versions of imagery (visual or kinesthetic). Participants will watch the video first at normal play speed and then in slow motion after a short break (30 secs to 1 min). Total training time will be approximately 20 mins which is consistent with the duration of the locomotor intervention and duration of stimulation. Active tDCS: The participants received a 20-minute active session of tDCS at a 2-milliamp current.
13
MI/Sham tDCS
The participants received sham tDCS current and participated in the Motor Imagery intervention. Motor Imagery (MI): Participants watched a standardized video sequence that consisted of an individual completing twenty walking trials (twenty video clips-each clip represents one trial). Participants were instructed to place their focus intently on the person performing the obstacle course and try to imagine themselves doing the skill. Periodically, a reminder would appear to help focus and redirect participant's attention to different aspects of the video or different versions of imagery (visual or kinesthetic). Participants will watch the video first at normal play speed and then in slow motion after a short break (30 secs to 1 min). Total training time will be approximately 20 mins which is consistent with the duration of the locomotor intervention and duration of stimulation. Sham tDCS: The participants received a 20-minute session of sham tDCS.
12
Control
The control group watched an unrelated (non stimulating) video for a duration equal to the MI groups' intervention tasks.
13
Total38

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up113

Baseline characteristics

CharacteristicMI/Active tDCSMI/Sham tDCSControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
13 Participants12 Participants13 Participants38 Participants
Age, Continuous22.42 years
STANDARD_DEVIATION 1.98
22.36 years
STANDARD_DEVIATION 2.06
24.1 years
STANDARD_DEVIATION 4.04
22.96 years
STANDARD_DEVIATION 2.69
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
11 Participants11 Participants10 Participants32 Participants
Sex: Female, Male
Male
2 Participants1 Participants3 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 130 / 120 / 13
other
Total, other adverse events
0 / 130 / 120 / 13
serious
Total, serious adverse events
0 / 130 / 120 / 13

Outcome results

Primary

Adherence to Interventions

number of sessions attended

Time frame: Baseline to 1 week follow up

ArmMeasureValue (MEAN)Dispersion
MI/Active tDCSAdherence to Interventions1.92 Numbers of session completedStandard Deviation 0.27
MI/Sham tDCSAdherence to Interventions1.91 Numbers of session completedStandard Deviation 0.28
ControlAdherence to Interventions1.77 Numbers of session completedStandard Deviation 0.43
Primary

Adverse Events in Each Study Arm

Number of unexpected and/or serious adverse events

Time frame: Baseline to 1 week follow up

ArmMeasureValue (NUMBER)
MI/Active tDCSAdverse Events in Each Study Arm0 number of adverse events
MI/Sham tDCSAdverse Events in Each Study Arm0 number of adverse events
ControlAdverse Events in Each Study Arm0 number of adverse events
Primary

Prefrontal Cortical Activity

Functional near infrared spectroscopy (fNIRS) monitor (OctaMon by Artinis Medical Systems), changes in oxygenated hemoglobin concentration (O2Hb) relative to a baseline task

Time frame: Baseline to 1 week follow up

ArmMeasureGroupValue (MEAN)Dispersion
MI/Active tDCSPrefrontal Cortical Activity20 minutes post Baseline (Post-Intervention)-0.62 μMStandard Deviation 0.7
MI/Active tDCSPrefrontal Cortical ActivityBaseline (Pre-Intervention)0.04 μMStandard Deviation 0.47
MI/Active tDCSPrefrontal Cortical Activity1 Week Follow up-0.61 μMStandard Deviation 0.51
MI/Sham tDCSPrefrontal Cortical Activity20 minutes post Baseline (Post-Intervention)-0.19 μMStandard Deviation 0.91
MI/Sham tDCSPrefrontal Cortical ActivityBaseline (Pre-Intervention)0.11 μMStandard Deviation 0.68
MI/Sham tDCSPrefrontal Cortical Activity1 Week Follow up0.24 μMStandard Deviation 1.11
ControlPrefrontal Cortical ActivityBaseline (Pre-Intervention)0.58 μMStandard Deviation 0.5
ControlPrefrontal Cortical Activity1 Week Follow up0.12 μMStandard Deviation 0.64
ControlPrefrontal Cortical Activity20 minutes post Baseline (Post-Intervention)0.20 μMStandard Deviation 0.81
Primary

Retention of Participants

number of participants completing intervention and follow-up assessment

Time frame: Baseline to 1 week follow up

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MI/Active tDCSRetention of Participants12 Participants
MI/Sham tDCSRetention of Participants11 Participants
ControlRetention of Participants10 Participants
Primary

Time to Completion

Recorded time to complete the obstacle course

Time frame: Baseline to 1 week follow up

ArmMeasureGroupValue (MEAN)Dispersion
MI/Active tDCSTime to Completion1 Week Follow up39.1 secondsStandard Deviation 3.98
MI/Active tDCSTime to CompletionPost-Test40.72 secondsStandard Deviation 3.45
MI/Active tDCSTime to CompletionBaseline/Pre46.60 secondsStandard Deviation 7.8
MI/Sham tDCSTime to CompletionPost-Test47.21 secondsStandard Deviation 4.3
MI/Sham tDCSTime to CompletionBaseline/Pre47.64 secondsStandard Deviation 6.42
MI/Sham tDCSTime to Completion1 Week Follow up45.43 secondsStandard Deviation 3.8
ControlTime to CompletionBaseline/Pre39.27 secondsStandard Deviation 8.1
ControlTime to Completion1 Week Follow up36.1 secondsStandard Deviation 8.3
ControlTime to CompletionPost-Test37.2 secondsStandard Deviation 7.8
Secondary

Kinesthetic and Visual Imagery Questionnaire (KVIQ)

The Kinesthetic and Visual Imagery Questionnaire (KVIQ-10) measures the ability to imagine movements. This test evaluates the subject's ability to see (visual imagery) and feel (kinesthetic imagery) movements. The KVIQ-10 total score ranges from 10 to 50 (visual and kinesthetic subscale scores each range from 5 to 25).The KVIQ consists of 10 items, (5 movements for each scale), each item being a separate movement followed by rating the ease or difficulty of generating those self-images on a 5-point Likert scale (where 1 = no image or sensation and 5 = Image as clear as seeing or as intense as executing the action). Higher scores reflect higher imagery abilities.

Time frame: Baseline to 1 week follow up

Population: The motor imagery/active tDCS and motor imagery/sham tDCS groups participated in the KVIQ-10 assessments, receiving motor imagery and active or sham transcranial direct current stimulation, respectively. These assessments evaluated their kinesthetic and visual imagery abilities, in order to compare their relative capabilities. The control group did not participate in the KVIQ-10 because they did not engage in motor imagery training, making the administration of the KVIQ-10 irrelevant for them.

ArmMeasureGroupValue (MEAN)Dispersion
MI/Active tDCSKinesthetic and Visual Imagery Questionnaire (KVIQ)External Imagery21.3 score on a scaleStandard Deviation 4.1
MI/Active tDCSKinesthetic and Visual Imagery Questionnaire (KVIQ)Kinesthetic Imagery22.9 score on a scaleStandard Deviation 4.7
MI/Sham tDCSKinesthetic and Visual Imagery Questionnaire (KVIQ)External Imagery22.7 score on a scaleStandard Deviation 3
MI/Sham tDCSKinesthetic and Visual Imagery Questionnaire (KVIQ)Kinesthetic Imagery21.7 score on a scaleStandard Deviation 4.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026